Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Systemic Lupus Erythematosus
NCT02741960Phase 4Completed
- Sponsor
- Renji Hospital
- Start
- May 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in systemic lupus erythematosus (SLE), sponsored by Renji Hospital. Started May 2016; status: completed.
02
Drugs
metformin
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT02741960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02741960.